Dataset from Multicenter, Open Label Study to Evaluate the Predictability of Early Response to Certolizumab Pegol (in Combination With Methotrexate) as Confirmed at Week 52 in Subjects With Moderate-severe Rheumatoid Arthritis (RA)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007917
下载链接
链接失效反馈官方服务：
资源简介：
The study aims to evaluate the predictability of early response to Certolizumab pegol in
combination with Methotrexate at one year in patients with moderate to severe rheumatoid
arthritis.
创建时间：
2024-11-26
